Choosing from Whole Cell and Acellular Pertussis Vaccines- Dilemma for the Developing Countries

  • Muhammad Ali SYED Infectious Diseases Research Group, Department of Microbiology, University of Haripur, Haripur, Pakistan
Keywords: No keywords##

Abstract

Choosing from Whole Cell and Acellular Pertussis Vaccines-  Dilemma for the Developing Countries

References

Mattoo S, Cherry J D (2005). Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev, 18 (2): 326-382.

Mooi FR, Zeddeman A, Van Gent M (2015). The pertussis problem: classical epidemiology and strain characterization should go hand in hand. J Pediatr(Rio J), 91 (4): 315-317.

Salmaso S., Mastrantonio P, Tozzi A E, Stefanelli P, Anemona A, Ciofi degli Atti M L, Giammanco A; Stage III Work-ing Group (2001). The Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy Italian experience. Pediatrics, 108(5): E81.

Winter K, Glaser C, Watt J, Harriman K (2014). Pertussis epidemic California 2014. MMWR Morb Mortal Wkly Rep, 63 (48): 1129-32.

Cherry J D. Why do Pertussis vaccines fail? Pediatrics 129: (5): 968-970.

Syed MA (2012). Adolescent and adult per-tussis - Lack of data from South Asian and African regions. Pak J Med Sci, 28 (3): 570.

Published
2017-02-12
How to Cite
1.
SYED MA. Choosing from Whole Cell and Acellular Pertussis Vaccines- Dilemma for the Developing Countries. Iran J Public Health. 46(2):272-273.
Section
Letter to the Editor